RxDoctor Payments Data

Bruce Lawrence

Podiatrist · Oceanside, CANPI 1417024852

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $809,438 of the $809,563 with a category attached, or 100.0%. 4 manufacturers reported payments, led by Smith+Nephew at 58.3% of the total. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$809,563in general payments, 2019–2025

Across 59 payments — averaging $13,721 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$472K
  • Integra Lifesciences Corporation$308K
  • Stryker$29K
  • Boston Scientific$125

What the payments were for

  • Royalty or licence$809,438100%
  • Food & beverage$1250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew19$471,731
Integra Lifesciences Corporation9$308,217
Stryker(2 entities)30$29,490
Boston Scientific1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$809,563 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Other podiatrist in Oceanside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →